Education, Patient-Focused Approach to Treating Chronic

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Education, Patient-Focused Approach to Treating Chronic Pain Are Keys to Preventing Opioid Abuse, Say Experts, Patients

SAN DIEGO, Sept. 4, 2014 (GLOBE NEWSWIRE) -- When leading health care professionals, chronic pain patients and pain community advocates gathered recently to kick off National Pain Awareness Month, their discussions quickly turned to the challenge of balancing public health concerns about opioid abuse and the unmet medical needs of millions of Americans whose daily lives are severely impacted by their chronic pain. The roundtables were hosted by Zogenix Inc. (Nasdaq: ZGNX ), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders. Zogenix also sponsored a survey of about 200 chronic pain patients to better understand this important stakeholder voice.

The health care professionals overwhelmingly agreed that education will play a critical role in combating the nation's prescription drug problem and strongly urged that chronic pain remain a top priority. "I believe that education is at the heart of this issue, and there needs to be mandatory education at the federal level. All opioid prescribers need to be educated (primary care, other specialists) about appropriate prescribing and learn the expected outcomes that allow continued prescribing," said Christopher Gharibo, M.D., Associate Professor; Director of Chronic Pain Management, Departments of Anesthesiology and Orthopedic Surgery, NYU Anesthesia Associates. For more from the expert panel discussion, click here .

Patients also stressed the importance of educating health care providers, legislators, news media and the general public on the distinctions between chronic pain and drug abuse. "We need to bust some myths about abuse and people with pain. People with chronic pain take medication to relieve the pain. People with addiction often move from medication to medication or use illegal medications because they have a craving they need to satisfy. That's a very different group of people and that message isn't out there," said Cindy Steinberg, Director of National Policy and Advocacy for U.S. Pain Foundation. For more from the patient panel discussion, click here .

An online survey of 202 U.S. adults who currently experience chronic pain conducted in August 2014 by Harris Poll on behalf of Zogenix provided additional context around the patient perspective. In terms of living with chronic pain, patients most commonly mentioned controlling the pain as a challenge in living with the condition (72 percent). The survey also showed the challenges patients face in achieving pain relief, as more than 90 percent of people surveyed currently taking prescription opioid medication at least occasionally experience breakthrough pain (91 percent). Of people who experience breakthrough pain, sleeping through the night is most negatively impacted (72 percent). Moreover, among those who experience breakthrough pain at least always to frequently, 41 percent take their opioid medication before they are due for another dose, potentially putting them at risk for unintentional overdose. i

The survey also revealed the need for better education, with the vast majority of patients citing an array of resources, including health care providers (76 percent), helpful for learning more about chronic pain and available treatment options. Further, better education could help patients navigate the challenges some face in securing access to treatment.

-  Over one-quarter of people living with chronic pain are not satisfied with the information their doctor has provided about available chronic pain treatment options (28 percent).

-  Twenty-eight percent of patients currently using a prescription opioid pain medication have had trouble getting their prescription filled.

"The voices of people living with severe chronic pain have been noticeably absent from most public conversations about prescription pain medications, and we are actively working with all stakeholders to ensure a balanced, constructive dialogue moving forward," said Roger Hawley, chief executive officer of Zogenix. "The candid feedback we've received from the pain community confirms that there is no 'one size fits all' solution to managing chronic pain. It also reaffirms that involving all participants in comprehensive system-wide approach can have a meaningful impact on prescription drug abuse in this country. As we work towards that goal, we have instituted sensible commercial practices that are already making a difference."

About the Survey

This survey was conducted online within the United States between August 22-27, 2014 among 202 adults aged 18 and older who are currently experiencing chronic pain by Harris Poll on behalf of Zogenix Inc. Figures for age, sex, race/ethnicity, education, region and household income were weighted where necessary to bring them into line with their actual proportions in the population. Propensity score weighting was used to adjust for respondents' propensity to be online.

All sample surveys and polls, whether or not they use probability sampling, are subject to multiple sources of error which are most often not possible to quantify or estimate, including sampling error, coverage error, error associated with non-response, error associated with question wording and response options, and post-survey weighting and adjustments. Therefore, Harris Poll avoids the words "margin of error" as they are misleading. All that can be calculated are different possible sampling errors with different probabilities for pure, unweighted, random samples with 100% response rates. These are only theoretical because no published polls come close to this ideal.

Respondents for this survey were selected from among those who have agreed to participate in Harris Poll surveys. The data have been weighted to reflect the composition of the adult population. Because the sample is based on those who agreed to participate in the Harris panel, no estimates of theoretical sampling error can be calculated.

About Nielsen & The Harris Poll

On February 3, 2014, Nielsen acquired Harris Interactive and The Harris Poll. Nielsen Holdings N.V. (NYSE: NLSN ) is a global information and measurement company with leading market positions in marketing and consumer information, television and other media measurement, online intelligence and mobile measurement. Nielsen has a presence in approximately 100 countries, with headquarters in New York, USA and Diemen, the Netherlands. For more information, visit  www.nielsen.com .

About Zogenix

Zogenix, Inc. (Nasdaq: ZGNX ) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with pain-related conditions and CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

For more information about Zogenix, please visit: www.Zogenix.com .

i Small base (n<100) - Results should be viewed as directional in nature

Media David Polk | Chandler Chicco Companies 310.309.1029 |

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 25

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 19

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Crocs to Present at Key Industry Conferences

Updated Category News Views 19

Crocs Set to Step into the Spotlight Alright, if there's one thing about Crocs, Inc. (NASDAQ: CROX) that never fails to surprise, it's how they constantly keep everyone on their toes. The iconic casual footwear brand with its whimsical, love-it-or-hate-it reputation is strapping in for not one but two hefty conferences. They've circled November 19 and December 1, 2026, on...

Continue Reading
Ainstein Expands Kansas Operations Amid Sensor Demand Surge

Updated Category News Views 16

Ainstein's Expansion Conquers New Heights in Radar Tech Ainstein just cranked open a whole new chapter right in the heart of Kansas. And believe me, it's not your average ribbon-cutting story. This shiny new facility in Lenexa is locked and loaded to roll out 44,000 radar sensors a year. It's part of a no-nonsense plan to keep up with soaring demand for their tech across...

Continue Reading
191 Schools Honored for Academic Growth Success

Updated Category News Views 80

Celebrating Educational Progress Nationwide In a world where numbers fly off the stock tickers and translate into dollar signs in some corner office, it's refreshingly humbling to find real gains being celebrated in the educational sector. Curriculum Associates has tipped their hat to 191 schools that have done something remarkable: they've pushed students to stretch...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 88

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 30

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
Arbor Realty Trust Faces Securities Fraud Allegations

Updated Category News Views 5

Securities Lawsuit Against Arbor Realty Trust Looms Well, here we go again. Another day, another securities lawsuit hitting the headlines. This time it's Arbor Realty Trust (NYSE: ABR) getting caught in the crossfire, accused of pulling the wool over investors' eyes. Seems like 'truth in advertising' is just part of the PR playbook for some big shots. Understanding the...

Continue Reading
SwitchBot's Hub 4: A Step Toward a Connected Future

Updated Category News Views 37

Turning a House Into a Smart Home Haven Out of Tokyo and onto the world stage, SwitchBot's got something new cooking that might just shake up the smart home scene. They've launched the Hub 4, a gadget that's like the Swiss Army knife of home control. For those who like things simple, this is a one-hub-to-rule-them-all kind of deal. 101,000 Reasons to Notice Now, they...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 41

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading

Top 5 Most Recently Viewed Articles

Aura Minerals Inc. Successfully Issues New Brazilian Debentures

Updated Category News Views 55

Aura Minerals Inc. Successfully Secures Funding through Debenture Issuance Aura Minerals Inc. (TSX: ORA) has recently made waves in the financial sector by successfully concluding the public offering of its 2nd issuance of debentures. The company announced this development following previous communications made on several dates earlier this year, confirming the completion...

Continue Reading
Emerging Trends in Clinical Trials Matching Software Market

Updated Category News Views 266

Growth of the Clinical Trials Matching Software Market The landscape of clinical trials is continually evolving, with the clinical trials matching software market expected to reach an impressive USD 501.86 million. This expansion points to a noteworthy compound annual growth rate (CAGR) of 13.14% between 2025 and 2032. Significance of AI and EHR Integration Market...

Continue Reading
Greystone Housing Plans Earnings Call to Discuss Q1 Results

Updated Category News Views 155

Greystone Housing to Host Earnings Conference Call Greystone Housing Impact Investors LP (NYSE: GHI) has announced it will be hosting an important earnings conference call for investors. This event is set to take place on a Wednesday at 4:30 p.m. Eastern Time. The focus of the call will be on discussing the financial results from the first quarter of the year....

Continue Reading
Successful Toyota Dealership Sale in the Automotive Market

Updated Category News Views 864

Performance Brokerage Services Facilitates Dealership Transaction Performance Brokerage Services, a leader in dealership buy-sell activities, has announced the successful sale of Premier Toyota. The dealership changed ownership from Robert Fisher to Kevin Wuepper, showcasing the brokerage firm’s expertise in the automotive sector. The Journey of Premier Toyota Founded...

Continue Reading
Investigation Launched into Sealed Air Corporation's Shareholder Deal

Updated Category News Views 193

Understanding the Investigation of Sealed Air Corporation In recent news, the Ademi Firm has initiated a probe into Sealed Air Corporation (NYSE: SEE), focusing on their proposed transaction with CD&R. This investigation is crucial because it centers on possible violations of fiduciary duty and legal requirements by the company’s board. The goal is to ensure that...

Continue Reading